[Bone histomorphometry: observations in cases of renal osteodystrophy]

Area of Science:

• Nephrology
• Endocrinology
• Histomorphometry

Background:

• Chronic renal failure (CRF) often leads to secondary hyperparathyroidism and renal osteodystrophy.
• Bone abnormalities in CRF include increased osteoclast activity and fibrous metaplasia.

Purpose of the Study:

• To evaluate the histomorphometric changes in bone tissue of patients with CRF-related osteodystrophy.
• To assess the efficacy of different active Vitamin D3 preparations in treating these bone abnormalities.

Main Methods:

• Histomorphometric analysis of bone tissue, measuring square areas and volumes.
• Quantification of osteoid tissue, osteoblasts, and osteoclasts in 7 CRF patients.
• Comparison of treatment effects between 25(OH)D3 and 1,25(OH)2D3.

Main Results:

• Patients exhibited secondary hyperparathyroidism, increased osteoclast activity, and osteomalacia.
• Treatment with Vitamin D3 active preparations reduced osteoclast reabsorption and osteoid tissue volume.
• 1,25(OH)2D3 showed a greater reduction in osteoclast activity and osteoid tissue compared to 25(OH)D3.

Conclusions:

• Active Vitamin D3, especially 1,25(OH)2D3, is effective in managing bone disease in CRF patients.
• Treatment normalizes histomorphometric parameters, reducing osteoclast-mediated bone resorption and osteoid accumulation.
• This highlights the therapeutic potential of specific Vitamin D metabolites in renal osteodystrophy.